THE USE OF RECOMBINANT FACTOR VIIA PRIOR TO DENTAL OF SURGICAL PROCEDURES IN CHILDREN WITH INHERITED PLATELET FUNCTION DEFECTS

被引：0
|
作者：
Sivamurthy, Krupa M. [1 ]
机构：
[1] St Christophers Hosp Children, Philadelphia, PA 19133 USA
来源：
PEDIATRIC BLOOD & CANCER | 2009年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：711 / 711
页数：1
相关论文
共 50 条
  • [41] Effects of recombinant factor VIIa on thrombin generation, platelet function and clot structure in blood with deficient prothrombin conversion.
    Carr, ME
    Martin, EJ
    Kuhn, JG
    Seremetis, SV
    BLOOD, 2002, 100 (11) : 87B - 87B
  • [42] RECOMBINANT FACTOR-VIIA FOR TREATMENT OF SERIOUS BLEEDS AND FOR COVER OF SURGICAL-PROCEDURES IN HEMOPHILIACS AND NONHAEMOPHILIACS WITH INHIBITORS TO FACTOR-VIII OR FACTOR-IX
    FELDSTEDT, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 282 - 282
  • [43] Use of recombinant factor VIIa for hip replacement surgery in a patient with severe factor XI deficiency and drug-induced platelet defect
    Dempfle, C. -E.
    Frietsch, T.
    Hoffmann, T.
    Ahmad-Nejad, P.
    Neumaier, M.
    Borggrefe, M.
    HAEMOPHILIA, 2008, 14 (05) : 1147 - 1149
  • [44] More on: Platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation
    Marietta, M
    Facchini, L
    Girardis, M
    Luppi, M
    Torelli, G
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 288 - 288
  • [45] Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical procedures
    Desprez, Dominique
    Drillaud, Nicolas
    Flaujac, Claire
    Volot, Fabienne
    Pan-Petesch, Brigitte
    Beurrier, Philippe
    Cussac, Vincent
    Feugeas, Olivier
    Pailler, Yoann
    Callegarin, Anamaria
    Trossaert, Marc
    de Raucourt, Emmanuelle
    HAEMOPHILIA, 2021, 27 (02) : 270 - 276
  • [46] Examining the feasibility of recombinant factor viia to compensate for physiological or drug-induced impairment of platelet function: an in-vitro study
    Haidl, H.
    Schlagenhauf, A.
    Grangl, G.
    Cvrin, G.
    Gallistl, S.
    Muntean, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 429 - 429
  • [47] Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-Center Cohort Study
    Witmer, Char M.
    Huang, Yuan-Shung
    Lynch, Kevin
    Raffini, Leslie J.
    Shah, Samir S.
    JOURNAL OF PEDIATRICS, 2011, 158 (05): : 820 - U155
  • [48] Platelet-free hemotherapy in patients with Bernard Soulier Syndrome (BSS): successful bleeding prophylaxis with recombinant factor VIIA (RFVIIA) for dental extraction
    Scharf, R. E.
    Bomke, B.
    Hoffmann, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 575 - 575
  • [49] Recombinant factor VIIa use in patients with the rarest forms of inherited coagulation-factor deficiencies: A study of cases from the www.haemostasis.com registry
    Smejkal P.
    Hassan M.
    Ingerslev J.
    Comparative Clinical Pathology, 2006, 15 (4) : 203 - 210
  • [50] Use of recombinant factor VIIa (rFVIIa) for bleeding episodes and surgical procedures in congenital factor VII deficiency (C7D): analysis from the hemophilia and thrombosis research society (HTRS) registry
    Saxena, K.
    Neufeld, E. J.
    Kraut, E. H.
    Cooper, D. L.
    HAEMOPHILIA, 2011, 17 (03) : 568 - 568
12345